Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services CRO which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials, has announced that
Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services CRO and a world leader in vaccine and antiviral testing using human challenge clinical trials, has announced a contract renewal
Open Orphan and Codagenix have received approval from the UK’s independent Medicines and Healthcare Products Regulatory Agency (MHRA) to conduct a Phase I study of its COVID-19 vaccine. The study
Pharmaceutical services company Open Orphan announced it had received approval from the MHRA on Monday and that it was ready to conduct a phase one study of Covi-Vac, the COVID-19
Open Orphan plc (LON:ORPH), a rapidly growing specialist pharmaceutical services CRO which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials, has announced the first
Venn Life Sciences, a subsidiary of Irish based Open Orphan, has been awarded two new contracts, including a Covid-19 drug trial. Open Orphan is a specialist clinical trials company which tests
Open Orphan plc (LON:ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials, has
After nearly a year of public advocacy and often rancorous ethical debate, human challenge trials for Covid-19 vaccines are getting off the ground in London. The UK government’s Covid-19 Vaccine
A unit of Irish stock market-listed Open Orphan is working with global scientific partners to draw up guidelines for running drug trials that involve deliberately infecting human volunteers. HIC-Vac is
Open Orphan plc (LON:ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials, has
© 2025 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
